BioNote, Inc. (KRX:377740)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,580.00
0.00 (0.00%)
At close: Jul 14, 2026

BioNote Company Description

BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea.

It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products.

The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents.

In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwaseong-si, South Korea.

BioNote, Inc.
CountrySouth Korea
Founded2003
IndustryMedical Devices
SectorHealthcare
Employees298
CEOByungKi Cho

Contact Details

Address:
22, Samsung 1-ro 4-gil
Hwaseong-si
South Korea
Phone82 3 1211 0516
Websitebionote.co.kr

Stock Details

Ticker Symbol377740
ExchangeKorea Stock Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyKRW
SIC Code2835

Key Executives

NamePosition
ByungKi ChoChief Executive Officer and Representative Director
GukMyeong LeeMD and Chief Financial Officer
GeumYoung OhSenior Accounting Manager
JeongHwan LimExecutive Director and GM of Management Headquarters and Legal Department
JeongHo KimExecutive Director
Hyeim ChoHead of Marketing Strategy Office and Executive Director
JuHwan SungMD and GM of Operations Support Office
IlJung KimExecutive Director
MyoungKyu ChungHead of Diagnostic Reagent Production Division
SangYoung JeongMD and Head of New Drug Development Business Division